The California Institute of Technology of Pasadena has received US Patent No. 8,129,176, "Integrated active flux microfluidic devices and methods." The claimed device is capable of detecting the presence of molecules, such as polynucleotides, proteins, or antigen/antibody complexes, that are correlated to a hybridization signal from an optically detectable reporter associated with the bound molecules. Hybridization probes are immobilized on a substrate exposed to channels of the device that form a closed loop, for circulation of sample to contact complementary probes.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.